Histological progression of follicular lymphoma associated with p53 mutation and rearrangement of the C-MYC gene

Hiroshima Journal of Medical Sciences

Volumn 45, Issue 2, 1996, Pages 69-73

  Takimoto, Yasuo ^a,c   Takafuta, Toshiro ^a   Imanaka, Fumio ^a,c   Kuramoto, Atsushi ^a   Sasaki, Naomi ^b   Nanba, Kôji ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Kure Mutual Aid Hospital   (Japan)

^c HIROSHIMA CITY ASA HOSPITAL   (Japan)

Author keywords

BCL2; C MYC; Follicular Lymphoma; p53; Transformation

Indexed keywords

AGED; ARTICLE; CASE REPORT; CELL TRANSFORMATION; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENETICS; HUMAN; LARGE CELL LYMPHOMA; MALE; MUTATION; ONCOGENE MYC; PATHOLOGY; TUMOR SUPPRESSOR GENE; UNDIFFERENTIATED LYMPHOMA;

AGED; CELL TRANSFORMATION, NEOPLASTIC; GENE REARRANGEMENT; GENES, MYC; GENES, P53; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, SMALL NONCLEAVED-CELL; MALE; MUTATION;

EID: 0030158627     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bissonnette, R.P., Echeverri, F., Mahboubi, A. and Green, D.R. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552-554.
2. Chin, K.-V., Ueda, K., Pastan, I. and Gottesman, M.M. 1992. Modulation of activity of the promoter of the human MDRI gene by ras and p53. Science 255: 459-462.
3. Cleary, M.L. and Sklar, J. 1985. Nucleotide sequence of a t (14:18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 82: 7439-7443.
4. Coco, F.L., Gaidano, G., Louie, D.C., Offit, K., Chaganti, R.S.K and Dalla-Favera, R. 1993. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82: 2289-2295.
5. Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R.C. and Croce, C.M. 1982. Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 79: 7824-7827.
6. DeJong, D., Voetdijk, B.M.H., Beverstock, G.C., van Ommen, G. J. B., Willemze, R. and Kluin, P.M. 1988 Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N. Engl. J. Med. 318: 1373-1378.
7. Evan, G.I., Wyllie, A.H., Gilbert, G.S., Littlewood T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
8. Fanidi, A., Harrington, E.A, and Evan, G.I. 1992. Cooperative interaction between c-myc and bcl-2 protooncogenes. Nature 359: 554-556.
9. Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M. and Dalla-Favera, R. 1991. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 88: 5413-5417.
10. Hockenbery, D. M., Nuñez, G., Milliman, C.L., Schreiber, R.D. and Korsmeyer, S.J. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-338.
11. Hockenbery, D.M., Oltvai, Z.N., Yin, X.-M., Milliman, C.L. and Korsmeyer, S.J. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251.
12. Korsmeyer, S.J., McDonnell, T.J., Nunez, G., Hockenbery, D. and Young, R. 1991. Bcl-2: B cell life, death and neoplasia. Curr. Topics. Microbiol. Immunol. 166: 203-207.
13. Liu, Y.-J., Johnson, G.D., Gordon, J. and MacLennan, I.C.M. 1992. Germinal centres in T-cell-dependent antibody responses. Immunol. Today 13: 17-21.
14. Matsuyama, F., Fukuhara, S., Oguma, S., Amakawa, R., Tanabe, S., Kato, I., Hayashi, T., Yamabe, H., Abe, M., Wakasa, H. and Okuma, M. 1992. Geographical aspects of bcl-2 gene involvement in Japanese patients with non-Hodgkin's B-cell lymphomas. Int. J. Hematol. 55: 71-79.
15. McDonnell, T.J., Deane, N., Platt, F.M., Nunez, G., Jaeger, U., McKearn, J.P. and Korsmeyer, S.J. 1989. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79-88.
16. McDonnell, T.J. and Korsmeyer, S.J. 1991. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t (14:18). Nature 349: 254-256.
17. Oltval, Z.N., Milliman, C.L. and Korsmeyer, S.J. 1993. Bcl-2 heterodimerizes in vitro with a conserved homolog, Bax, that accelerates programed cell death. Cell 74: 609-619.
18. Osada, H., Seto, M., Ueda, R., Emi, N., Takagi, N., Obata, Y., Suchi, T. and Takahashi, T. 1989. bcl-2 gene rearrangement analysis in Japanese B cell lymphoma; novel bcl-2 recombination with immunoglobulin k chain gene. Jpn. J. Cancer. Res. 80: 711-715.
19. Sander, C.A., Yano, T., Clark, H.M., Harris, C., Longo, D.L., Jaffe, E.S. and Raffeld, M. 1993. p53 mutation is associated with progression in follicular lymphomas. Blood 82: 1994-2004.
20. Shi, Y., Glynn, J.M., Guilbert, L.J., Cotter, T.G., Bissonnette, R.P. and Green, D.R. 1992. Role for c-myc in activation-induced apoptotic cell death in Tcell hybridomas. Science 257: 212-214.
21. Strasser, A., Harris, A.W., Bath, M.L. and Cory, S. 1990. Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331-333.
22. Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Hirai, H., Ishikawa, F. and Takaku, F. 1991. Mutations of the p53 gene in lymphoid leukemia. Blood 77: 1153-1156.
23. Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S. and Leder, P. 1982. Translocation of the c-myc gene into the immuoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA 79: 7837-7841.
24. Thangavelu, M., Olopade, O., Beckman, E., Vardiman, J.W., Larson, R.A., McKeithan, T.W., Le Beau, M.M. and Rowley, J.D. 1990. Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t (14:18) (q32:q21) and t (8:14) (q24:q32) or t (8:22) (q24:q11). Genes. Chrom. Cancer 2: 147-158.
25. Tsujimoto, Y., Finger, L.R., Yunis, J., Nowell, P.C. and Croce, C.M. 1984. Cloning of the chromosome breakpoint of neoplastic B cells with the t (14:18) chromosome translocation. Science 226: 1097-1099.
26. Vaux, D.L., Cory, S. and Adams, J.M. 1988. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
27. Weiss, L.M., Warnke, R.A., Sklar, J. and Cleary, M.L. 1987. Molecular analysis of the t (14:18) chromosomal translocation in malignant lymphomas. N. Engl. J. Med. 317: 1185-1189.
28. Yano, T., Jaffe, E.S., Longo, D.L. and Raffeld, M. 1992. Myc rearrangements in histologically progressed follicular lymphomas. Blood 80: 758-767.
29. Yunis, J.J., Frizzera, G., Oken, M.M., McKenna, O.J., Theologides, A. and Arnesen, M. 1987. Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. N. Engl. J. Med. 316: 79-84.